Detalles de la búsqueda
1.
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.
Br J Cancer
; 130(11): 1783-1794, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38519705
2.
Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).
Oncologist
; 28(3): 278-e166, 2023 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36426809
3.
Implication of changes in PD-L1 expression during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen in esophageal squamous cell carcinoma.
Esophagus
; 20(2): 281-289, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36484900
4.
Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L.
Cancer Sci
; 113(1): 221-228, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704312
5.
Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifen.
Invest New Drugs
; 40(1): 194-197, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463889
6.
Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts.
Br J Cancer
; 124(5): 914-924, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33299131
7.
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.
Oncologist
; 26(4): e588-e596, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33325566
8.
Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L).
BMC Cancer
; 21(1): 1121, 2021 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34663250
9.
Safety and efficacy of cetuximab-containing chemotherapy after immune checkpoint inhibitors for patients with squamous cell carcinoma of the head and neck: a single-center retrospective study.
Anticancer Drugs
; 32(1): 95-101, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32976215
10.
CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M-positive lung cancer after osimertinib.
Int J Clin Oncol
; 26(9): 1628-1639, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34117553
11.
Clinical implications of bronchoscopy for immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer.
BMC Pulm Med
; 21(1): 155, 2021 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33964920
12.
[fam-] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification.
Int J Cancer
; 145(12): 3414-3424, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31087550
13.
Mutational activation of the epidermal growth factor receptor down-regulates major histocompatibility complex class I expression via the extracellular signal-regulated kinase in non-small cell lung cancer.
Cancer Sci
; 110(1): 52-60, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30390416
14.
Correction: Implication of changes in PD-L1 expression during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen in esophageal squamous cell carcinoma.
Esophagus
; 20(2): 290, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36658273
15.
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer.
Invest New Drugs
; 35(4): 529-536, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28317087
16.
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
BMC Med
; 18(1): 111, 2020 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32312270
17.
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade.
J Clin Invest
; 134(7)2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38557498
18.
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor Immunity.
Cancer Discov
; 14(5): 752-765, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38227896
19.
Liquid biopsy detects genomic drivers in NSCLC without EGFR mutations by single-plex testing: WJOG13620L.
Cancer Med
; 12(23): 21097-21110, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37948122
20.
Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer.
Sci Rep
; 13(1): 19729, 2023 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957228